StudyRareStudyRare
Log in to add personal notes on this page.

A Southeast Asian couple has a stillborn infant with hydrops fetalis. Hemoglobin electrophoresis shows only Hb Bart's (γ4). The parents are both α-thalassemia trait carriers with --/αα genotype.

Usually AR; HBA1 and HBA2 (chromosome 16), the two alpha globin genes. Most disease alleles are deletions, which remove one or both genes on a chromosome and reduce alpha globin chain production.

Types (by # of functioning α genes):

ConditionGenotypePhenotype
Silent carrier-α/ααNormal
α-thal trait--/αα or -α/-αMild microcytic anemia
HbH disease--/-αModerate hemolytic anemia, HbH (β4)
Hb Bart's hydrops--/--Lethal, hydrops fetalis, Hb Bart's (γ4)

Each chromosome 16 carries HBA1 and HBA2, so a person normally has four alpha globin alleles. Alpha globin pairs with gamma globin in fetal hemoglobin (HbF, α2γ2) and with beta globin in adult HbA (α2β2). The defect is quantitative: each inactivated allele lowers alpha chain output, and the more alleles lost, the greater the imbalance with the partner chains. HBA2 makes two to three times more alpha globin than HBA1, so losing HBA2 costs more.

The unpaired partner chains explain the findings. With all four alleles lost, HbF and HbA cannot form; the fetus makes mainly Hb Bart (γ4), which binds oxygen too tightly to deliver it, and the severe anemia causes heart failure and hydrops. With three lost, excess beta chains form HbH (β4), which precipitates as red cell inclusions, more so under oxidative stress, and the damaged cells are cleared as hemolysis.

Deletions cause most Hb Bart and HbH disease. Non-deletion variants (splicing, polyadenylation, stop codon, frameshift, hyper-unstable globins) generally impair alpha globin synthesis more, which is why non-deletional HbH disease is more severe. Deleting the upstream MCS-R2 regulatory element causes alpha-thalassemia even with both genes intact.

  • --/αα (cis deletions) common in Southeast Asian populations → risk for Bart's hydrops
  • -α/-α (trans deletions) common in African populations → lower risk for Bart's hydrops
  • CBC shows microcytic, hypochromic anemia (low MCV) with normal or elevated RBC count and normal iron studies (distinguishes from iron deficiency)
  • Hemoglobin electrophoresis or HPLC: HbH (β4) in HbH disease, Hb Bart's (γ4) at birth or in hydrops; HbA2 is normal or low (unlike beta-thalassemia)
  • HBA1/HBA2 deletion analysis (MLPA or gap-PCR) confirms genotype and identifies cis (--/αα) vs trans (-α/-α) for reproductive risk
  • Carrier testing and prenatal diagnosis indicated when both partners carry α-globin deletions
  • Silent carrier and trait: no treatment; genetic counseling and avoidance of unnecessary iron supplementation
  • HbH disease: folic acid, intermittent transfusion during hemolytic or aplastic crises, splenectomy in selected cases, iron monitoring
  • Hb Bart's hydrops: usually lethal in utero; rare survivors require intrauterine transfusion and lifelong transfusion support
  • HSCT is potentially curative for transfusion-dependent disease

Hb Barts = Bad. Hb Barts is seen in an unborn Baby with fetal hydrops due to 4-gene deletion of alpha-thalassemia.

The letter "H" in HbH has 4 points. Represents the beta-globin tetramer.

Alpha is the most "social" Hb. Alpha-globin pairs with all other globin chains (β, γ, δ), which is why alpha-thalassemia affects multiple hemoglobin types.

Hemoglobinopathies and hemoglobin electrophoresis
Hemoglobinopathies and hemoglobin electrophoresis